| Literature DB >> 29216875 |
Tao Zuo1, Jun Fu1, Zhengyi Ni2, Baojun Chen3.
Abstract
BACKGROUND: Pulmonary inflammatory myofibroblastic tumor (PIMT) is a rare disease in China and its incidence is much lower than that of tuberculosis. PIMT accounts for only 0.04-1.2% of all lung tumors. PIMT can occurs in any age and nearly every part of the body. The clinical symptoms and radiological features of PIMT are nonspecific. Diagnosis is only made on the basis of histopathologic or immunohistochemical evaluation of the postoperation resected tissue. The therapeutic approach to PIMT should rely mainly on complete surgical resection. CASEEntities:
Keywords: Pulmonary inflammatory myofibroblastic tumor; Tuberculosis
Mesh:
Year: 2017 PMID: 29216875 PMCID: PMC5721699 DOI: 10.1186/s13019-017-0670-9
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Chest computed tomography show right upper and middle lobes pneumonia and right middle lobe atelectasis (a). And a pulmonary hilar mass involve the right pulmonary artery (b, c). The review of thoracic CT scans revealed the mass did not progress during the period of ATT (d). A postoperative thoracic CT showed there is no recurrence after six months. Photomicrograph of the tumor specimen indicated spindle cells with infiltration of lymphocytes, plasma cells, and foamy histiocytes (f)